A5065681552- Global Cancer Incidence and Screening
- Multiple and Secondary Primary Cancers
- Colorectal Cancer Screening and Detection
- COVID-19 Clinical Research Studies
- Lung Cancer Diagnosis and Treatment
- SARS-CoV-2 and COVID-19 Research
- Nutritional Studies and Diet
- Global Health Care Issues
- Lung Cancer Treatments and Mutations
- Vaccine Coverage and Hesitancy
- Cancer Risks and Factors
- Alcohol Consumption and Health Effects
- Cutaneous Melanoma Detection and Management
- Global Public Health Policies and Epidemiology
- Health and Wellbeing Research
- COVID-19 epidemiological studies
- Bladder and Urothelial Cancer Treatments
- Clinical practice guidelines implementation
- Nutrition and Health in Aging
- Genetic factors in colorectal cancer
- Economic and Financial Impacts of Cancer
- Medical Imaging and Pathology Studies
- Cancer Diagnosis and Treatment
- Birth, Development, and Health
- Health disparities and outcomes
National Institute of Oncology
2021-2024
Országos Pszichiátriai és Neurológiai Intézet
2022-2024
World Health Organization - Pakistan
2024
Centre International de Recherche sur le Cancer
2021-2023
National Cancer Registry
2023
Hungarian Central Statistical Office
2017
University of Pecs
2017
Abstract Introduction In 2020, bladder cancer (BC) was the seventh most prevalent in world, with 5-year prevalence of more than 1.7 million cases. Due to main risk factors—smoking and chemical exposures—associated BC, it is considered a largely preventable avoidable cancer. An overview BC mortality can allow an insight not only into global factors, but also varying efficiency healthcare systems worldwide. For this purpose, study analyzes national estimates for 2020 projected future trends up...
In Hungary, the pandemic waves in late 2021 and early 2022 were dominated by Delta Omicron SARS-CoV-2 variants, respectively. Booster vaccines offered with one or two doses for vulnerable population during these periods.
Background In late 2021, the pandemic wave was dominated by Delta SARS-CoV-2 variant in Hungary. Booster vaccines were offered for vulnerable population starting from August 2021. Methods The nationwide HUN-VE 3 study examined effectiveness and durability of primary immunization single booster vaccinations prevention infection, Covid-19 related hospitalization mortality during wave, compared to an unvaccinated control without prior infection. Results included 8,087,988 individuals who 18–100...
Objectives Lung cancer (LC) is the leading cause of death in 2020, responsible for almost one five (18.0%) deaths. This paper provides an overview descriptive epidemiology LC based on national mortality estimates 2020 from International Agency Research Cancer (IARC), and context recent tobacco control policies. Design setting For this study, age-standardised rates per 100 000 person-years 185 countries by sex were obtained GLOBOCAN database stratified Human Development Index (HDI). deaths...
Introduction Type 2 diabetes mellitus is a risk factor for severe COVID-19 infection and associated with increased of complications. The present study aimed to investigate effectiveness persistence different COVID vaccines in persons or without during the Delta wave Hungary. Research design methods Data sources were national registry data from National Public Health Center Insurance Fund on total Hungarian population. adjusted incidence rate ratios corresponding 95% CIs derived mixed-effect...
Background Despite well-documented clinical differences across breast-cancer (BC) molecular subtypes and relevant changes in therapeutic interventions over the past decades, there remains a significant lack of up-to-date epidemiologic data real-world outcomes, particularly Central Eastern Europe. Methods This was nationwide, retrospective study using claims databases Hungarian National Health Insurance Fund (NHIF) that included patients who were newly diagnosed with BC between 2011 2020....
Background The assessment of cancer survival is crucial for evaluating advancements in management. As part the nationwide HUN-CANCER EPI study, we examined net Hungarian patient population 2011–2019. Methods Using extracted data from National Health Insurance Fund (NHIF) database, study aimed to assess probabilities various types over past decade by Pohar Perme Estimator method, providing insights sex and age-specific differences enabling comparative analysis with other European countries....
Life expectancy (LE) is an indicator of societal progress among rapidly aging populations. In recent decades, the displacement deaths from cardiovascular disease (CVD) and cancer have been key drivers in further extending LE on continent, though improvements vary markedly by country, sex, over time. This study provides a comparative overview age-specific contributions CVD to increasing 27 European Union member states, plus U.K.
Among malignant diseases, lung cancer has one of the highest mortality and incidence. Most epidemiological studies conclude that Hungary faces most severe burden in association with this disease. However, for various reasons estimates population-based show discrepancies. In study, an intense data cleansing was performed on cases were reported to Hungarian National Cancer Registry 2018, major clinico-pathological parameters as well survival characteristics described. Our figures compared...
Assessment of population-based cancer survival may provide the most valuable feedback about effectiveness oncological surveillance and treatment.
Background This nationwide study examined breast cancer (BC) incidence and mortality rates in Hungary between 2011–2019, the impact of Covid-19 pandemic on 2020 using databases National Health Insurance Fund (NHIF) Central Statistical Office (CSO) Hungary. Methods Our nationwide, retrospective included patients who were newly diagnosed with (International Codes Diseases ICD)-10 C50) Jan 1, 2011 Dec 31, 2020. Age-standardized (ASRs) calculated European Standard Populations (ESP). Results...
Abstract Background In Hungary, the pandemic waves in late 2021 and early 2022 were dominated by Delta Omicron SARS-CoV-2 variants, respectively. Booster vaccines offered with one or two doses for vulnerable population during these periods. Methods Findings The nationwide HUN-VE 2 study examined effectiveness of primary immunization, single booster, double booster vaccination prevention Covid-19 related mortality waves, compared to an unvaccinated control without prior infection same risk...
Abstract Background In late 2021, the pandemic wave was dominated by Delta SARS-CoV-2 variant in Hungary. Booster vaccines were offered starting from August 2021. Methods The nationwide HUN-VE 3 study examined effectiveness and durability of primary immunization single booster vaccinations on SARS-CoV-2-related infection, hospitalization mortality during wave. Results population included 8,087,988 individuals aged 18–100 years at beginning pandemic. During wave, after adjusting for age, sex,...
Introduction: In international comparison, Hungary is in the forefront of cancer incidence and mortality statistics. Based on paper-based death certificates, statistics are compiled by Hungarian Central Statistical Office, while population-based measures incidences performed National Cancer Registry. Objective: Linking records these two independent databases can highlight their weaknesses provide an opportunity to reconcile verify collected data, which may emphasize need expand current data...
Background: The nationwide HUN-CONCORD study examined cancer incidence and mortality rates in Hungary from 2011 to 2019.Methods: Using data the National Health Insurance Fund (NHIF) Central Statistical Office (CSO), our retrospective analyzed newly diagnosed malignancies between Jan 1, 2011, Dec 31, 2019. Age-standardized were calculated for all different tumor types using both 1976 2013 European Standard Populations (ESP).Findings: number of cases decreased 60,554 56,675 2011–2019. much...
The nationwide HUN-CANCER EPI study examined cancer incidence and mortality rates in Hungary from 2011 to 2019.
Objective The Hungarian Undiagnosed Lung Cancer (HULC) study aimed to explore the potential reasons for missed LC (lung cancer) diagnosis by comparing healthcare and socio-economic data among patients with post-mortem diagnosed those who were during their lives. Methods This nationwide, retrospective used databases of Central Statistical Office (HCSO) National Health Insurance Fund (NHIF) identify died between January 1, 2019 December 31, lung cancer (population A) or lifetime B). Patient...